bf/NASDAQ:AGLE_icon.jpeg

NASDAQ:AGLE

Aeglea BioTherapeutics, Inc.

  • Stock

USD

Last Close

11.26

27/11 21:00

Market Cap

48.63M

Beta: 1.76

Volume Today

43.24K

Avg: 725.60K

PE Ratio

−0.18

PFCF: −0.56

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
Dec '24
revenue
6.08M
-
4.63M
23.94%
5.21M
12.47%
3.89M
25.30%
18.74M
-
2.33M
87.57%
886K
61.96%
cost of revenue
964K
-
gross profit
6.08M
-
4.63M
23.94%
5.21M
12.47%
3.89M
25.30%
18.74M
-
2.33M
87.57%
-78K
103.35%
selling and marketing expenses
general and administrative expenses
2.07M
-
5.95M
186.74%
8.39M
41.10%
10.07M
19.96%
12.63M
25.49%
15.73M
24.56%
21.84M
38.83%
27.32M
25.07%
28.53M
4.44%
39.95M
40.01%
45.78M
14.59%
selling general and administrative expenses
2.07M
-
5.95M
186.74%
8.39M
41.10%
10.07M
19.96%
12.63M
25.49%
15.73M
24.56%
21.84M
38.83%
27.32M
25.07%
28.53M
4.44%
39.95M
40.01%
45.78M
14.59%
research and development expenses
6.83M
-
11.45M
67.69%
18.14M
58.41%
22.82M
25.75%
36.72M
60.94%
64.60M
75.93%
59.64M
7.68%
57.07M
4.31%
58.58M
2.65%
89.50M
52.79%
162.79M
81.88%
other expenses
-2K
-
-36K
1,700%
-42K
16.67%
-57K
35.71%
-63K
10.53%
-5K
92.06%
-122K
2,340%
-7K
94.26%
113.74M
1,624,942.86%
cost and expenses
8.90M
-
17.40M
95.42%
26.53M
52.49%
32.88M
23.92%
49.35M
50.09%
80.33M
62.78%
81.48M
1.43%
84.39M
3.57%
87.11M
3.23%
243.19M
179.17%
operating expenses
8.90M
-
17.40M
95.42%
26.53M
52.49%
32.88M
23.92%
49.35M
50.09%
80.33M
62.78%
81.48M
1.43%
84.39M
3.57%
87.11M
3.23%
243.19M
179.17%
208.57M
14.24%
interest expense
837K
-
ebitda
-7.44M
-
-11.23M
50.87%
-21.57M
92.11%
-26.99M
25.14%
-44.05M
63.25%
-80.33M
82.35%
-80.48M
0.19%
-65.65M
18.43%
-84.78M
29.14%
-127.82M
50.76%
-207.97M
62.70%
operating income
-8.90M
-
-11.31M
27.08%
-21.91M
93.60%
-27.68M
26.34%
-45.46M
64.27%
-80.33M
76.70%
-81.48M
1.43%
-65.65M
19.43%
-84.78M
29.14%
-242.30M
185.80%
-208.57M
13.92%
depreciation and amortization
19K
-
89K
368.42%
132K
48.31%
249K
88.64%
293K
17.67%
418K
42.66%
996K
138.28%
1.58M
58.23%
1.57M
0.57%
964K
38.48%
total other income expenses net
-1.44M
-
-2K
99.86%
-36K
1,700%
-42K
16.67%
-57K
35.71%
2.08M
3,749.12%
588K
71.73%
-11K
101.87%
830K
7,645.45%
-96.51M
11,728.07%
599K
100.62%
income before tax
-10.35M
-
-11.29M
9.16%
-21.70M
92.10%
-27.24M
25.52%
-44.35M
62.83%
-78.25M
76.45%
-80.89M
3.37%
-65.66M
18.83%
-83.95M
27.86%
-338.82M
303.59%
-207.97M
38.62%
income tax expense
1.44M
-
-22K
101.52%
-36K
63.64%
-42K
16.67%
-57K
35.71%
-2.56M
4,392.98%
-593K
76.84%
141K
123.78%
-136K
196.45%
-26K
80.88%
51K
296.15%
net income
-10.35M
-
-11.29M
9.16%
-21.70M
92.10%
-27.24M
25.52%
-44.35M
62.83%
-75.69M
70.68%
-80.30M
6.09%
-65.80M
18.06%
-83.81M
27.38%
-338.79M
304.21%
-208.02M
38.60%
weighted average shs out
6.82M
-
11.43M
67.59%
9.79M
14.33%
15.13M
54.50%
20.82M
37.64%
31.95M
53.44%
53.37M
67.05%
65.74M
23.18%
84.28M
28.19%
7.34M
91.29%
374.39M
5,000.43%
weighted average shs out dil
6.82M
-
11.43M
67.59%
9.79M
14.33%
15.13M
54.50%
20.82M
37.64%
31.95M
53.44%
53.37M
67.05%
65.74M
23.18%
84.28M
28.19%
7.34M
91.29%
374.39M
5,000.43%
eps
-1.52
-
-0.99
34.87%
-2.22
124.24%
-1.80
18.92%
-2.13
18.33%
-2.37
11.27%
-1.50
36.71%
-1
33.33%
-0.99
1.00%
-46.15
4,561.62%
-0.56
98.79%
epsdiluted
-1.52
-
-0.99
34.87%
-2.22
124.24%
-1.80
18.92%
-2.13
18.33%
-2.37
11.27%
-1.50
36.71%
-1
33.33%
-0.99
1.00%
-46.15
4,561.62%
-0.56
98.79%

All numbers in USD (except ratios and percentages)